Recent advances in cardio-oncology: a report from the 'Heart Failure Association 2019 and World Congress on Acute Heart Failure 2019'

被引：33

作者：

Anker, Markus S. ^{[1
,2
,3
,4
]}

Hadzibegovic, Sara ^{[1
,2
,3
,4
]}

Lena, Alessia ^{[1
,2
,3
,4
]}

Belenkov, Yury ^{[5
]}

Bergler-Klein, Jutta ^{[6
]}

de Boer, Rudolf A. ^{[7
]}

Farmakis, Dimitrios ^{[8
,9
]}

von Haehling, Stephan ^{[10
]}

Iakobishvili, Zaza ^{[11
,12
]}

Maack, Christoph ^{[13
]}

Pudil, Radek ^{[14
]}

Skouri, Hadi ^{[15
]}

Cohen-Solal, Alain ^{[16
,17
]}

Tocchetti, Carlo G. ^{[18
,19
]}

Coats, Andrew J. S. ^{[20
]}

Seferovic, Petar M. ^{[21
,22
]}

Lyon, Alexander R. ^{[23
,24
]}

机构：

[1] Charite, Dept Cardiol, Div Cardiol & Metab, Berlin, Germany

[2] Berlin Inst Hlth, Ctr Regenerat Therapies BCRT, Berlin, Germany

[3] DZHK German Ctr Cardiovasc Res, Partner Site Berlin, Berlin, Germany

[4] Charite Campus Benjamin Franklin, Dept Cardiol, Berlin, Germany

[5] Sechenov Med Univ, Moscow, Russia

[6] Med Univ Vienna, Dept Cardiol, Vienna, Austria

[7] Univ Groningen, Univ Med Ctr Groningen, Dept Cardiol, Groningen, Netherlands

[8] Univ Cyprus, Med Sch, Nicosia, Cyprus

[9] Natl & Kapodistrian Univ Athens, Athens Univ Hosp Attikon, Heart Failure Unit, Dept Cardiol,Cardiooncol Clin, Athens, Greece

[10] Georg August Univ, Univ Gottingen, German Ctr Cardiovasc Med DZHK, Dept Cardiol & Pneumol,Heart Ctr Gottingen,Med Ct, Gottingen, Germany

[11] Tel Aviv Univ, Clalit Hlth Fund, Dept Community Cardiol, Tel Aviv, Israel

[12] Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel

[13] Univ Clin Wurzburg, CHFC, Wurzburg, Germany

[14] Univ Hosp, Fac Med, Dept Med Cardioangiol 1, Hradec Kralove, Czech Republic

[15] Amer Univ Beirut, Med Ctr, Dept Internal Med, Beirut, Lebanon

[16] Paris Univ, BIOCANVAS Biomarqueurs Cardiovasc, Lariboisiere Hosp, Dept Cardiol, Paris, France

[17] Paris Univ, BIOCANVAS Biomarqueurs Cardiovasc, U942 INSERM, Paris, France

[18] Univ Naples Federico II, Dept Translat Med Sci, Naples, Italy

[19] Univ Naples Federico II, Interdept Ctr Clin & Translat Sci CIRCET, Naples, Italy

[20] IRCCS San Raffaele, Rome, Italy

[21] Univ Belgrade, Med Ctr, Fac Med, Belgrade, Serbia

[22] Univ Belgrade, Med Ctr, Heart Failure Ctr, Belgrade, Serbia

[23] Royal Brompton Hosp, London, England

[24] Imperial Coll London, London, England

来源：

ESC HEART FAILURE | 2019年 / 6卷 / 06期

关键词：

Cardiotoxicity; Heart failure; Cancer; IMMUNE CHECKPOINT INHIBITOR; BREAST-CANCER SURVIVORS; CHRONIC KIDNEY-DISEASE; INDEPENDENT PREDICTOR; PALLIATIVE CARE; CO-MORBIDITIES; POSITION PAPER; CARDIOTOXICITY; PREVALENCE; ECHOCARDIOGRAPHY;

D O I：

10.1002/ehf2.12551

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

While anti-cancer therapies, including chemotherapy, immunotherapy, radiotherapy, and targeted therapy, are constantly advancing, cardiovascular toxicity has become a major challenge for cardiologists and oncologists. This has led to an increasing demand of cardio-oncology units in Europe and a growing interest of clinicians and researchers. The Heart Failure 2019 meeting of the Heart Failure Association of the European Society of Cardiology in Athens has therefore created a scientific programme that included four dedicated sessions on the topic along with several additional lectures. The major points that were discussed at the congress included the implementation and delivery of a cardio-oncology service, the collaboration among cardio-oncology experts, and the risk stratification, prevention, and early recognition of cardiotoxicity. Furthermore, sessions addressed the numerous different anti-cancer therapies associated with cardiotoxic effects and provided guidance on how to treat cancer patients who develop cardiovascular disease before, during, and after treatment.

引用

页码：1140 / 1148

页数：9

共 101 条

[1] Cardiotoxicity of Anticancer Drugs: The Need for Cardio-Oncology and Cardio-Oncological Prevention [J].